Naina Bhargava's Profile

MPharm (Master of Pharmacy)

Naina Bhargava

Naina Bhargava is a pharmaceutical sciences graduate and is currently pursuing a master's degree from a prestigious government university. She has a keen interest in creating compelling and crisp content, especially in the field of medicinal sciences, and is a national-level awardee for an elocution view more..

Written / Edited / Medically Reviewed

New Blood Thinner Reduces Bleeding Risk in Atrial Fibrillation Patients

New Blood Thinner Reduces Bleeding Risk in Atrial Fibrillation Patients

Researchers have found that Factor XI inhibitors, such as abelacimab, reduce bleeding risks in atrial fibrillation patients more effectively than standard anticoagulants.

Drug News
Prostate Cancer: Are Genomic Tests the Future of Risk Assessment?

Prostate Cancer: Are Genomic Tests the Future of Risk Assessment?

A systematic review highlights the potential of genomic tests in prostate cancer treatment decisions but calls for more data on their effectiveness.

Men´s Health News
The Truth Behind Popular Weight-Loss Shots: Breakthrough or Critical Risks?

The Truth Behind Popular Weight-Loss Shots: Breakthrough or Critical Risks?

GLP-1RA weight-loss drugs provide health benefits but also pose risks, including pancreatitis, kidney problems, and gastrointestinal issues.

Obesity News
Planning Parenthood Through IVF? Study Warns Against Air Pollution’s Impact

Planning Parenthood Through IVF? Study Warns Against Air Pollution’s Impact

A study found that exposure to air pollution negatively affects embryo development during IVF, with organic carbon having the most harmful impact.

Environmental Health
FDA Approves Marketing of Nicotine Pouches: A Safer Way to Quit?

FDA Approves Marketing of Nicotine Pouches: A Safer Way to Quit?

The FDA has authorized the marketing of 20 ZYN nicotine pouches after finding they pose lower health risks than cigarettes and may help users quit more harmful tobacco products.

Drug News